Every chemical substance manufactured in or imported into the European Union falls under REACH — the Registration, Evaluation, Authorisation and Restriction of Chemicals regulation (EC 1907/2006). For cosmetics companies, this creates a regulatory layer that operates alongside, and sometimes overlaps with, EU Cosmetics Regulation 1223/2009. Understanding how these two frameworks interact is essential for any R&D team formulating products for the EU market.
What REACH Requires and How It Applies to Cosmetics
REACH establishes a comprehensive framework for the registration, evaluation, and restriction of chemical substances across all industries. Its core principle is that manufacturers and importers of chemicals bear the burden of proving that the substances they place on the market can be used safely. Substances manufactured or imported above one tonne per year must be registered with the European Chemicals Agency (ECHA), accompanied by technical dossiers and, for higher volumes, chemical safety reports.
Cosmetic products themselves are largely exempt from certain REACH provisions — specifically, the Cosmetics Regulation takes precedence for the safety assessment of finished cosmetic products. However, this exemption applies only to the finished product. The individual raw materials and chemical substances used as ingredients in cosmetics are fully subject to REACH. This means that every surfactant, preservative, emollient, fragrance compound, colorant, and active ingredient in a cosmetic formula must comply with REACH registration requirements before it can legally be used in manufacturing.
Substances of Very High Concern (SVHCs)
One of REACH's most significant mechanisms for cosmetics R&D teams is the identification of Substances of Very High Concern. SVHCs are chemicals that have been identified as having particularly serious effects on human health or the environment. A substance may be classified as an SVHC if it is carcinogenic, mutagenic, or toxic to reproduction (CMR); persistent, bioaccumulative, and toxic (PBT); very persistent and very bioaccumulative (vPvB); or if there is scientific evidence of equivalent concern, such as endocrine disruption.
ECHA maintains and regularly updates the Candidate List of SVHCs. Once a substance is placed on the Candidate List, it may subsequently be moved to the Authorisation List (Annex XIV of REACH), at which point its use requires explicit authorisation from ECHA. The Restriction List (Annex XVII) imposes conditions on or prohibits specific uses of listed substances. For cosmetics formulators, monitoring these lists is not optional — an ingredient that was compliant last year may face restrictions this year as new toxicological evidence emerges or as regulatory priorities shift.
The Overlap with Cosmetics Regulation Annexes
The Cosmetics Regulation maintains its own annexes of prohibited substances (Annex II), restricted substances (Annex III), permitted colorants (Annex IV), preservatives (Annex V), and UV filters (Annex VI). These annexes are informed by, but do not perfectly mirror, REACH classifications. A substance may be restricted under REACH without yet being listed in the Cosmetics Regulation annexes, or it may be permitted in cosmetics at specific concentrations while facing broader restrictions under REACH for other applications. This regulatory asymmetry means that checking only the Cosmetics Regulation annexes is insufficient — a complete compliance assessment must also evaluate REACH status.
How REACH Impacts Raw Material Procurement
REACH compliance is not solely the concern of the formulator — it cascades through the supply chain. Cosmetics companies that import raw materials from outside the EU must ensure that those substances are registered under REACH by the importer or by an Only Representative appointed by the non-EU manufacturer. When a registration lapses, a substance is de-registered, or a new restriction enters force, the downstream user — the cosmetics manufacturer — is affected immediately.
This creates a documentation burden that scales with portfolio complexity. A cosmetics company working with 200 raw materials must track REACH registration status, SVHC status, and any applicable restrictions for every single substance. For companies sourcing from multiple suppliers across different jurisdictions, the complexity multiplies further, as the same INCI-named substance from different suppliers may have different registration holders, different impurity profiles, and different compliance documentation.
How Software Manages REACH Compliance at Scale
Tracking REACH status manually — through spreadsheets, periodic supplier questionnaires, and ad hoc checks of the ECHA database — is feasible for a small portfolio. It becomes untenable as the number of raw materials, formulas, and target markets grows. Purpose-built formulation software addresses this by integrating REACH data directly into the raw material database.
In a platform like Labify® Beauté, each of the 100,000+ raw material profiles in the database includes structured data on regulatory status — not just INCI name and function, but REACH registration status, SVHC classification, restriction applicability, and links to relevant regulatory documentation. When a formulator selects an ingredient, the platform can flag REACH-related concerns at the point of formulation, not months later during a regulatory review. When ECHA updates the Candidate List or a new restriction enters force, the kAI layer can propagate alerts across all formulas containing affected substances, identifying which products in the portfolio require reformulation or documentation updates.
Connecting REACH Data to the Full Product Lifecycle
REACH compliance is not a one-time check at the point of formulation. It is a continuous obligation that affects procurement (ensuring suppliers maintain valid registrations), raw material traceability (linking each batch of incoming material to its REACH registration and compliance documentation), safety assessment (incorporating REACH-derived toxicological data into the Cosmetic Product Safety Report), and Safety Data Sheet generation (where REACH classification and hazard data must be accurately reflected).
A vertically integrated platform that connects formulation, procurement, manufacturing, and regulatory documentation can enforce this continuity automatically. When the REACH status of a substance changes, the impact propagates through the entire system — from the raw material database to the formulas that use it, to the safety assessments that reference it, to the Safety Data Sheets that describe it. No manual reconciliation, no risk of outdated information persisting in one system while another has been updated.
The Strategic Value of Proactive REACH Monitoring
Regulatory change under REACH is not hypothetical — it is continuous. ECHA publishes new SVHC identifications, restriction proposals, and authorisation decisions on a regular cadence. For cosmetics companies, the cost of reacting to these changes after they take effect — emergency reformulations, supply chain disruptions, product withdrawals — is vastly higher than the cost of monitoring and preparing in advance. Software that maintains a living, continuously updated view of REACH status across every ingredient in the portfolio transforms REACH compliance from a reactive burden into a strategic advantage.
For any cosmetics R&D team operating in the EU regulatory environment, REACH is not a separate concern from cosmetics regulation — it is the foundation on which raw material compliance is built. Treating it as such, with the right data infrastructure, is what separates companies that manage regulatory change from those that are managed by it.